DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

1160 combination of methimazole and cholestyramine. J Clin
Endocrinol Metab, 1996, 81:3191–3193.
Metso S, Auvinen A, Huhtala H, et al. Increased cancer incidence
after radioiodine treatment for hyperthyroidism. Cancer,
2007, 109:1972–1979.
Miller MD, Crofton KM, Rice DC, Zoeller RT. Thyroid-disrupting
chemicals: Interpreting upstream biomarkers of adverse outcomes.
Environ Health Perspect, 2009, 117:1033–1041.
Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil
and methimazole on fetal thyroid status in mothers
with Graves’ hyperthyroidism. J Clin Endocrinol Metab, 1997,
82:3633–3636.
Monga V, Meena CL, Kaur N, Jain R. Chemistry and biology of
thyrotropin-releasing hormone (TRH) and its analogs. Curr
Med Chem, 2008, 27:18–33.
Moreno JC, Klootwijk W, van Toor H, et al. Mutations in the
iodotyrosine deiodinase gene and hypothyroidism. N Engl J
Med, 2008, 358:1811–1818.
Morte B, Manzano J, Scanlan T, et al. Deletion of the thyroid
hormone receptor alpha 1 prevents the structural alterations of
the cerebellum induced by hypothyroidism. Proc Natl Acad
Sci USA, 2002, 99:3985–3989.
Mortimer RH, Cannell GR, Addison RS, et al. Methimazole and
propylthiouracil equally cross the perfused human term placental
lobule. J Clin Endocrinol Metab, 1997, 82:3099–3102.
Müller B, Zulewski H, Huber P, et al. Impaired action of thyroid
hormone associated with smoking in women with hypothyroidism.
N Engl J Med, 1995, 333:964–969.
Mullis-Jansson SL, Argenziano M, Corwin S, et al. A randomized
double-blind study of the effect of triiodothyronine on
cardiac function and morbidity after coronary bypass surgery.
J Thorac Cardiovasc Surg, 1999, 117:1128–1134.
Murphy E, Williams GR. The thyroid and the skeleton. Clin
Endocrinol, 2004, 61: 285–298.
National Academy of Sciences/National Research Council
(NAS/NRC). Health Implications of Perchlorate Ingestion.
National Academy Press, Washington, DC, 2005.
Nauman J, Wolff J. Iodide prophylaxis in Poland after the
Chernobyl reactor accident: Benefits and risks. Am J Med,
1993, 94:524–532.
Nayak B, Burman K. Thyrotoxicosis and thyroid storm.
Endocrinol Metab Clin North Am, 2006, 35:663–686.
Neumann S, Kleinau G, Constanzi S, et al. A low-molecular
weight antagonist for the human thyrotropin receptor with
therapeutic potential for hyperthyroidism. Endocrinology,
2008, 149:5945–5950.
Ocasio CA, Scanlan TS. Characterization of thyroid hormone
receptor alpha (TRalpha)-specific analogs with varying innerand
outer-ring substituents. Bioorg Med Chem, 2008, 16:
762–770.
O’Shea PJ, Williams GR. Insight into the physiological actions
of thyroid hormone receptors from genetically modified mice.
J Endocrinol, 2002, 175:553–570.
Pacini F, Castangna MG. Diagnostic and therapeutic use of
recombinant human TSH (rTSH) in differentiated thyroid cancer.
Best Pract Res Clin Endocrinol Metab, 2008, 22:
1009–1021.
Pacini F, Gasperi M, Fugazzola L, et al. Testicular function in
patients with differentiated thyroid carcinoma treated with
radioiodine. J Nucl Med, 1994, 35:1418–1422.
SECTION V
HORMONES AND HORMONE ANTAGONISTS
Papakostas GI, Cooper-Kazaz R, Appelhof BC, et al.
Simultaneous initiation (coinitiation) of pharmacotherapy with
triiodothyronine and a selective serotonin reuptake inhibitor
for major depressive disorder: A quantitative synthesis of doubleblind
studies. Int Clin Psychopharmacol, 2009, 24:19–25.
Peeters RP, Wouters PJ, Kaptein E, et al. Reduced activation and
increased inactivation of thyroid hormone in tissues of critically
ill patients. J Clin Endocrinol Metab, 2003, 88:3202–3211.
Refetoff S. Inherited thyroxine-binding globulin abnormalities
in man. Endocr Rev, 1989, 10:275–293.
Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to
thyroid hormone: Genetic defects in hormone receptors, cell
transporters and deiodination. Best Pract Res Clin Endocrinol
Metab, 2007, 21:277–305.
Regard JB, Kataoka H, Cano DA, et al. Probing cell typespecific
functions of Gi in vivo identifies GPCR regulators of
insulin secretion. J Clin Invest, 2007, 117:4034–4043.
Reuss ML, Paneth N, Pinto-Martin JA, et al. The relation of transient
hypothyroxinemia in preterm infants to neurologic development
at two years of age. N Engl J Med, 1996, 334:
821–827.
Rittmaster RS, Abbott EC, Douglas R, et al. Effect of methimazole,
with or without L-thyroxine, on remission rates in
Graves’ disease. J Clin Endocrinol Metab, 1998, 83:
814–818.
Rodien P, Bremont C, Sanson ML, et al. Familial gestational
hyperthyroidism caused by a mutant thyrotropin receptor
hypersensitive to human chorionic gonadotropin. N Engl J
Med, 1998, 339:1823–1826.
Ron E, Doody MM, Becker DV, et al. Cancer mortality following
treatment for adult hyperthyroidism. Cooperative
Thyrotoxicosis Therapy Follow-up Study Group. JAMA, 1998,
280:347–355.
Rose SR, Brown RS, Foley T, et al. Update of newborn screening
and therapy for congenital hypothyroidism. Pediatrics,
2006, 117:2290–2303.
Roti E, Cozani R, Braverman LE. Adverse effects of iodine on
the thyroid. Endocrinologist, 1997, 7:245–254.
Rubio IG, Medeiros-Neto G. Mutations of the thyroglobulin
gene and its relevance to thyroid disorders. Curr Opin
Endocrinol Diabetes Obes, 2009, 16:373–378.
Saberi M, Utiger RD. Serum thyroid hormone and thyrotropin
concentrations during thyroxine and triiodothyronine therapy.
J Clin Endocrinol Metab, 1974, 39:923–927.
Santini F, Pinchera A, Marsili A, et al. Lean body mass is a major
determinant of levothyroxine dosage in the treatment of thyroid
disease. J Clin Endocrinol Metab, 2005, 90:124–127.
Sato H, Hattori M, Fujieda M, et al. High prevalence of antineutrophil
cytoplasmic antibody positivity in childhood onset
Graves’ disease treated with propylthiouracil. J Clin
Endocrinol Metab, 2000, 85:4270–4273.
Scanlan TS, Suchland KL, Hart ME, et al. 3-Iodothyronamine is
an endogenous and rapid-acting derivative of thyroid hormone.
Nat Med, 2004, 10:638–642.
Schussler GC. The thyroxine-binding proteins. Thyroid, 2000,
10:141–149.
Sdano MT, Falciglia M, Welge JA, Steward DL. Efficacy of thyroid
hormone suppression for benign thyroid nodules: Metaanalysis
of randomized trials. Otolaryngol Head Neck Surg,
2005, 133:391–396.